References
- Nagy I. Z. On the true role of oxygen free radicals in the living state, aging, and degenerative disorders. Ann. N. Y. Acad. Sci. 2001; 928: 187–199, [PUBMED], [INFOTRIEVE], [CSA]
- Chatterjee P. K., Cuzzocrea S., Brown P. A., Zacharowski K., Stewart K. N., Mota‐Filipe H., Thiemermann C. Tempol, a membrane‐permeable radical scavenger, reduces oxidant stress‐mediated renal dysfunction and injury in the rat. Kidney Int. 2000; 58(2)658–673, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bauer V., Bauer F. Reactive oxygen species as mediators of tissue protection and injury. Gen. Physiol. Biophys. 1999; 18: 7–14, [PUBMED], [INFOTRIEVE]
- Chatterjee P. K., Cuzzocrea S., Thiemermann C. Inhibitors of poly (ADP‐ribose) synthetase protect rat proximal tubular cells against oxidant stress. Kidney Int. 1999; 56(3)973–984, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Humes H. D. Role of calcium in pathogenesis of acute renal failure. Am. J. Physiol. 1986; 250: F579–F589, [PUBMED], [INFOTRIEVE]
- Baliga R., Ueda N., Walker P. D., Shah S. V. Oxidant mechanisms in toxic acute renal failure. Drug Metab. Rev. 1999; 31(4)971–997, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oldham K. M., Bowen P. E. Oxidative stress in critical care: is antioxidant supplementation beneficial?. J. Am. Diet. Assoc. 1998; 98(9)1001–1008, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Andreoli S. P., McAteer J. A. Reactive oxygen molecule‐mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int. 1990; 38: 785–794, [PUBMED], [INFOTRIEVE]
- Paller M. S, Jacob H. S. Cytochrome P‐450 mediates tissue‐damaging hydroxyl radical formation during reoxygenation of the kidney. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 7002–7006, [PUBMED], [INFOTRIEVE], [CSA]
- Ueda N., Guidet B., Shah S. V. Gentamicin‐induced mobilization of iron from renal cortical mitochondria. Am. J. Physiol. 1993; 265: F435–F439, [PUBMED], [INFOTRIEVE]
- Agrawal R., Sharma P. K., Rao G. S. Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents. Toxicology 2001; 168(3)223–230, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Trenam C. W., Blake D. R., Morris C. J. Skin inflammation: reactive oxygen species and the role of iron. J. Invest. Dermatol. 1992; 99(6)675–862, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Baliga R., Zgang Z., Shah S. Role of cytochrome P‐450 in hydrogen peroxide‐induced cytotoxicity to LLC‐PK1 cells. Kidney Int. 1996; 50: 1118–1124, [PUBMED], [INFOTRIEVE]
- Liu H., Baliga M., Baliga R. Effect of cytochrome P450 2E1 inhibitors on cisplatin‐induced cytotoxicity to renal proximal tubular epithelial cells. Anticancer Res. 2002; 22(2A)863–868, [PUBMED], [INFOTRIEVE], [CSA]
- Klaassen C. D. Casarett and Doull's toxicology. The Basic Science of Poisons5th Ed. McGraw‐Hill, London 1995; 737–740
- Diaz‐Gomez M. I., Castro G. D., Delgado D. E., Layno A. M.A., Costantini M. H., Castro J. A. Cytochrome P450 reductase‐mediated anaerobic biotransformation of ethanol to 1‐hydroxyethyl‐free radicals and acetaldehyde. Toxicology 2000; 154: 113–122, [CSA], [CROSSREF]
- Holt S., Roy G., Mitra S., Upton P. B., Bogdanffy M. S., Swenberg J. A. Deficiency of N‐methylpurine‐DNA‐glycosylate expression in nonparenchymal cells, the target cell for vinyl chloride and vinyl fluoride. Mutat. Res. 2000; 460: 105–115, [PUBMED], [INFOTRIEVE]
- Zangar R. C., Benson J. M., Burnett V. L., Springer D. L. Cytochrome P450 2E1 is the primary enzyme responsible for low‐dose carbon tetrachloride metabolism in human liver microsomes. Chem. Biol. Interact. 2000; 125: 233–243, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sakurai K., Cederbaum A. I. Oxidative stress and cytotoxicity induced by ferric‐nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol. Pharmacol. 1998; 54: 1024–1035, [PUBMED], [INFOTRIEVE], [CSA]
- Castillo T., Koop D. R., Kamimura S., Triadafilopoulos G., Tsukamoto H. Role of cytochrome P‐450 2E1 in ethanol‐, carbon tetrachloride‐ and iron‐dependent microsomal lipid peroxidation. Hepatology 1992; 16: 992–996, [PUBMED], [INFOTRIEVE]
- Dai Y., Rashba‐Step J., Cederbaum A. I. Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 1993; 32: 6928–6937, [PUBMED], [INFOTRIEVE]
- Agarwal A. J., Balla G., Croatt A. J., Vercellotti G. M., Nath K. A. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am. J. Physiol. 1996; 271: F814–F823, [PUBMED], [INFOTRIEVE]
- Yusof M., Yildiz D., Ercal N. n‐acetyl‐l‐cysteine protects against delta‐aminolevulinic acid‐induced 8‐hydroxydeoxyguanosine formation. Toxicol. Lett. 1999; 106: 41–47, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Saito H., Ohi H., Sugata E., Murayama N., Fujita Y., Higuchi. Purification and characterization of a cytochrome P450 from liver microsomes of Xenopus laevis. Arch. Biochem. Biophys. 1997; 345(1)56–64, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mari M., Cederbaum A. I. Induction of catalase, alpha, and microsomal glutathione S‐transferase in CYP2E1 overexpressing HepG2 cells and protection against short‐term oxidative stress. Hepatology 2001; 33(3)652–661, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding. Anal. Biochem. 1976; 72: 248–254, [PUBMED], [INFOTRIEVE]
- Watt K. C., Plopper C. G., Buckpitt A. R. Measurement of cytochrome P450 2E1 activity in rat tracheobronchial airways using high‐performance liquid chromatography with electrochemical detection. Anal. Biochem. 1997; 248: 26–30, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Liu H., Shah S. V., Baliga R. Cytochrome P‐450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. Am. J. Physiol., Renal. Physiol. 2001; 280(1)F88–F94
- Bysani G. K., Kennedy T. P., KY N., Rao N. V., Blaze C. A., Hoidal J. R. Role of cytochrome P‐450 in reperfusion injury of the rabbit lung. J. Clin. Invest. 1990; 86: 1434–1441, [PUBMED], [INFOTRIEVE]
- Hsieh H. J., Cheng C. C., Wu S. T., Chiu J. J., Wung B. S., Wang D. L. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear‐induced c‐fos expression. J. Cell. Physiol. 1998; 175(2)156–162, [PUBMED], [INFOTRIEVE]
- Barbouti A., Doulias P. T., Zhu B. Z., Frei B., Galaris D. Intracellular iron, but not copper, plays a critical role in hydrogen peroxide‐induced DNA damage. Free Radic. Biol. Med. 2001; 31(4)490–498, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang Y., Luo Z. The effects of deferoxamine on bovine pulmonary endothelial cell injury induced by hydrogen peroxide. Hunan Yike Daxue Xuebao 1997; 22(3)203–205, [PUBMED], [INFOTRIEVE], [CSA]
- Libra S., Pagano D., Curella G., Litrico V., Cancelliere M., Audibert D., LaTerra S., Gruttadauria S., Pappalardo A., D'Alessandro M. Experimental research on the use of deferoxamine in the prevention of renal damage from acute ischemia. Ann. Ital. Chir. 1999; 70(4)569–573, [PUBMED], [INFOTRIEVE], [CSA]
- Liu H., Baliga M., Baliga R. Effect of cytochrome P450 2E1 inhibitors on cisplatin‐induced cytotoxicity to renal proximal tubular epithelial cells. Anticancer Res. 2002; 22(2A)863–868, [PUBMED], [INFOTRIEVE], [CSA]
- Cederbaum A. I., Wu D., Mari M., Bai J. CYP2E1‐dependent toxicity and oxidative stress in HepG2 cells. Free Radic. Biol. Med. 2001; 31(12)1539–1543, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guengerich F. P., Johnson W. W. Kinetics of ferric cytochrome P450 reduction by NADPH‐cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems. Biochemistry 1997; 36(48)14741–14750, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morimoto M., Hagbjork A. L., Nanji A. A., Ingelman‐Sundberg M., Lindros K. O., Fu P. C., Albano E., French S. W. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 1993; 10(6)459–464, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chen Q., Cederbaum A. I. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol. Pharmacol. 1998; 53(4)638–648, [PUBMED], [INFOTRIEVE], [CSA]
- French M., S. W., Reitz R. C., Koop D., Klopfenstein B., Estes K., Clot P., Ingelman‐Sundberg M., Albano E. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats. J. Nutr. 1997; 127(Suppl. 5)907S–911S, [PUBMED], [INFOTRIEVE]
- Morimoto M., Reitz R. C., Morin R. J., Nguyen K., Ingelman‐Sundberg M., French S. W. CYP‐2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet. J. Nutr. 1995; 125(12)2953–2964, [PUBMED], [INFOTRIEVE]
- Emery M. G., Jubert C., Thummel K. E., Kharasch E. D. Duration of cytochrome P‐450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half‐life after single‐dose disulfiram administration in humans. J. Pharmacol. Exp. Ther. 1999; 291(1)213–219, [PUBMED], [INFOTRIEVE], [CSA]
- Lauriault V. V., Khan S., O'Brien P. J. Hepatocyte cytotoxicity induced by various hepatotoxins mediated by cytochrome P‐450IIE1: protection with diethyldithiocarbamate administration. Chem. Biol. Interact. 1992; 81: 271–289, [PUBMED], [INFOTRIEVE], [CROSSREF]